21 - 23 May
The medical technology and biotechnology industries are characterized by extremely short product life cycles. In order to configure the product development process and the commercial launch optimally, the Fraunhofer IPT is developing quality and risk management systems specifically for these sectors and provides technical support to companies in the form of market and process analysis.Additionally, with the increasing digitalization and data availability, novel challenges and potentials are evolving in the context of the so - called 'industry 4.0#. We help our customers to transform their production systems into highly flexible, interconnected and adaptable units. The Fraunhofer IPT has already implemented numerous aspects of networked, adaptive production in its research and development projects with partners from a wide range of industrial sectors.
The requirement for differentiated stem cells is increasing both in disease modelling and in the screening of active ingredients. In the drive to provide these in ...
Many biotechnological processes profit from innovative technical solutions and an increasing degree of automation - this includes white, red and green biotechnology ...
In order to be able to detect an illness and to provide optimal treatment, diagnostic solutions are essential for clinical applications. At the Fraunhofer IPT, we ...
The Fraunhofer IPT is a strong partner in the development of innovative solutions for demanding manufacturing tasks. Our strengths lie in the highly precise processing ...